BridgeBio Pharma, Inc. (BBIO)
67.31
-0.99
(-1.45%)
USD |
NASDAQ |
Sep 17, 16:00
67.00
-0.31
(-0.46%)
Pre-Market: 09:01
BridgeBio Pharma 30-Day Average Daily Volume : 2.212M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 2.212M |
| September 16, 2026 | 2.215M |
| September 15, 2026 | 2.112M |
| September 14, 2026 | 2.024M |
| September 11, 2026 | 2.034M |
| September 10, 2026 | 2.059M |
| September 09, 2026 | 2.037M |
| September 08, 2026 | 2.032M |
| September 04, 2026 | 2.035M |
| September 03, 2026 | 2.053M |
| September 02, 2026 | 2.067M |
| September 01, 2026 | 2.065M |
| August 31, 2026 | 2.063M |
| August 28, 2026 | 2.053M |
| August 27, 2026 | 2.037M |
| August 26, 2026 | 2.120M |
| August 25, 2026 | 2.128M |
| August 24, 2026 | 2.171M |
| August 21, 2026 | 2.246M |
| August 20, 2026 | 2.401M |
| August 19, 2026 | 3.011M |
| August 18, 2026 | 2.970M |
| August 17, 2026 | 2.969M |
| August 14, 2026 | 2.980M |
| August 13, 2026 | 2.983M |
| Date | Value |
|---|---|
| August 12, 2026 | 3.042M |
| August 11, 2026 | 3.062M |
| August 10, 2026 | 3.068M |
| August 07, 2026 | 3.871M |
| August 06, 2026 | 3.892M |
| August 05, 2026 | 3.991M |
| August 04, 2026 | 3.992M |
| August 03, 2026 | 4.020M |
| July 31, 2026 | 4.102M |
| July 30, 2026 | 4.084M |
| July 29, 2026 | 4.092M |
| July 28, 2026 | 4.115M |
| July 27, 2026 | 4.093M |
| July 24, 2026 | 4.105M |
| July 23, 2026 | 4.107M |
| July 22, 2026 | 4.117M |
| July 21, 2026 | 4.124M |
| July 20, 2026 | 4.164M |
| July 17, 2026 | 4.171M |
| July 16, 2026 | 4.214M |
| July 15, 2026 | 4.253M |
| July 14, 2026 | 4.459M |
| July 13, 2026 | 4.469M |
| July 10, 2026 | 4.429M |
| July 09, 2026 | 4.317M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.644M |
| Ionis Pharmaceuticals, Inc. | 3.082M |
| Pfizer Inc. | 34.32M |
| Vertex Pharmaceuticals, Inc. | 1.044M |
| BioMarin Pharmaceutical, Inc. | 2.156M |